Role of bilevel positive airway pressure in the management of preterm newborns who have received surfactant

Authors:

Abstract
Aim:  Surfactant given during brief intubation followed by immediate extubation on nasal continuous positive airway pressure [Intubation‐Surfactant‐Extubation (InSurE) approach] is used to treat respiratory distress syndrome in newborns. Our aim was to evaluate whether bilevel positive airway pressure (BiPAP) after InSurE failure is able to prevent the need for mechanical ventilation (MV).Methods:  Chart data of infants with a birth weight Results:  Six of twenty‐two (27%) and 14 of the 38 (37%) infants failed InSurE in the two groups, respectively (p > 0.05). Need for MV was 27% in the historical control group versus 0% in the BiPAP group (risk estimate, 3.38; 95% CI, 2.24, 5.09; p = 0.001).Conclusions:  BiPAP reduced the need for MV after InSurE failure.

This publication has 22 references indexed in Scilit: